Corporate Compliance

Pharmaceutical company pays Florida $8.5 million in Medicaid fraud settlement

Compliance Monitor, December 16, 2009

Want to receive articles like this one in your inbox? Subscribe to Compliance Monitor!

Roxane Laboratories, Inc.will pay $8.5 million to the state of Florida to settle claims that the company inflated  prices for medications reimbursed by the Florida Medicaid system, according to a Department of Justice (DOJ) press release.
 
Roxane, and its affiliates, Boehringer Ingelheim Roxane, Inc., Boehringer Ingelheim Pharmaceuticuals, Inc., Boehringer Ingelheim Corporation, and Ben Venue Laboratories, Inc., allegedly amplified medication prices in order to receive higher reimbursement from the Florida Medicaid program.
 
Medicaid’s administrator, The Agency for Health Care Administrations, will receive more than $4.4 million from the settlement. The State of Florida’s General Revenue Fund will deposit more than $1.69 million from the settlement, and $188,000 will fund rewards for the whistleblowers who reported the fraud.



Want to receive articles like this one in your inbox? Subscribe to Compliance Monitor!

Most Popular

Related Articles